← FDA Drug Approvals (Drugs@FDA)
TERBUTALINE SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2004-05-26
Drug application
- FDA Application #
ANDA076887- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TERBUTALINE SULFATE
- Generic name
- TERBUTALINE SULFATE
- Active ingredients
- TERBUTALINE SULFATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2004-05-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown